Evolus Initiates Nuceiva® Launch in Germany and Austria

Author's Avatar
Feb 27, 2023

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, has commenced the commercial launch of Nuceiva® (botulinum toxin type A) in Germany and Austria, and is now available for direct order and delivery to customers.